| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.077 | 0.2 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.2 |